Eli Lilly and Company
Engineered Antibody Compounds and Conjuates Thereof
Last updated:
Abstract:
Engineered antibody compounds and conjugates thereof, are provided, said antibody compounds and conjugates thereof are useful as agents for cancer immunotherapy.
Status:
Application
Type:
Utility
Filling date:
14 Jun 2018
Issue date:
21 May 2020